Skip to content
lsd.com

Indication

Neurotransmitter Agents

4 registered trials testing Ketamine for this indication, 2 recruiting now.

4
Registered trials
2
Recruiting
1
In Phase 3

Stay told

When a new trial opens

Research alerts

Get a notification when a trial for Neurotransmitter Agents trials starts recruiting

This registry is rebuilt every day. If no trial is recruiting for you today, that can change within weeks.

This form sends your email address and the topic of this page to Brevo, our email provider, which stores them on servers in the European Union. We never sell that address, never share it with anyone, and never use it for advertising. One email deletes it. What is held, and where.

Trials

All 4 trials for Neurotransmitter Agents

TrialStatusPhaseSubstanceSites
Nebulized Ketamine for the Treatment of Major Depressive DisorderNCT06752759 · Theresa Jacob, PhD, MPHRecruitingPhase 3ketamine1
Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant DepressionNCT06511908 · National Institute of Mental Health (NIMH)RecruitingPhase 2ketamine1
Oral Aspirin + Ketamine as Adjunct to Oral Antidepressant Therapy for DepressionNCT05615948 · Theresa Jacob, PhD, MPHCompletedPhase 4ketamine1
Lidocaine and Magnesium and Ketamine in Gynecological SurgeryNCT04622904 · Aretaieion University HospitalUnknown statusNot applicableketamine1

Records from ClinicalTrials.gov API v2, data build 2026-08-25. Indications are the sponsors’ own words. LSD.com reports registered clinical research. It is not medical advice, it is not a recommendation to take any substance, and trial listings are not endorsements. Talk to a clinician.